Found 2310 matching trials
MB-CART20.1 Lymphoma PHASE1 This trial is a phase I/II trial to assess safety, dose finding and feasibi...
Show More Location
University Hospital of Cologne - Clinic for Internal Medicine I
Learn More & Join Trial
CAR-T Therapy in Relapsed or Refractory Haematopoietic and Lymphoid Malignancies PHASE1 This is an open, single-arm, phase I clinical study to evaluate efficacy an...
Show More Location
Hematology Department, Hebei Medical University Fourth Hospital
Learn More & Join Trial
Study Evaluating the Safety and Efficacy of JWCAR029 in Adult Subjects With Relapsed and Refractory B-cell Non-Hodgkin Lymphoma PHASE1 This is a single arm, open-label, dose escalation clinical study to evaluat...
Show More Learn More & Join Trial
Autologous Hematopoietic Stem Cell Boost Study After CAR-T Therapy PHASE2 This is a prospective, single-arm, open study to observe the efficacy and s...
Show More Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
CD19/CD22 CAR-T Consolidation in R/R Aggressive B-Cell Lymphoma After Second-Line Therapy PHASE2 The purpose of this study is to determine the efficacy and safety of CD22/C...
Show More Location
Chinese PLA General Hospital, Beijing, Beijing 100853
Learn More & Join Trial
Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy PHASE3 The goal of this clinical study is to compare the study drug KITE-753 versu...
Show More Location
City of Hope Arizona
Learn More & Join Trial
CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients PHASE1 The purpose of this study is to evaluate the safety and effectiveness of CA...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Efficacy of Universal CAR-T Cells (UWD-CD19) Combined with Immunosuppressants in the Treatment of Refractory Autoimmune Diseases PHASE1 Autoimmune diseases refer to a common category of diseases caused by the im...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma PHASE1 This is a phase I, interventional, single-arm, open-label, dose-finding tre...
Show More Location
Froedtert & the Medical College of Wisconsin
Learn More & Join Trial
Allogeneic CAR-T(CT0890B) in NKG2DL+ R/R AML PHASE1 A Clinical Study to Investigate the Safety and Efficacy of CT0890B in Patie...
Show More Location
Peking University People's Hospital
Learn More & Join Trial